{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:30:21Z","timestamp":1782603021187,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary neuroendocrine carcinomas of the gallbladder and biliary tract are rare, with pure large cell neuroendocrine carcinomas (LCNEC) being exceedingly rare and with a particularly poor prognosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a review of published data on biliary tract large cell neuroendocrine carcinomas in PubMed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Preliminary search revealed over 2000 results but we found only 12 cases of pure large cell neuroendocrine carcinomas of biliary tract noted in literature to date. Because it commonly presents with non-specific symptoms of abdominal pain and jaundice, diagnosis is made after resection with histo-pathological and immunohistochemical analysis. These cancers are particularly aggressive with high recurrence rates, most often presenting with metastasis to regional lymph nodes and\/or the liver resulting in a poor prognosis. Overall, complete surgical excision with systemic chemotherapy is the treatment mainstay. If the cancer is unresectable due to multiple metastases, medical management with systemic chemotherapy is the primary treatment modality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The prognosis of hepatobiliary LCNEC remains poor with median survival of only 11\u2009months from initial diagnosis. Studies focusing on high grade neuroendocrine carcinoma are needed to enhance our understanding of biology and therapeutics in this rare but aggressive cancer.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-019-1230-2","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:04:07Z","timestamp":1574337847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Biliary tract large cell neuroendocrine carcinoma: current evidence"],"prefix":"10.1186","volume":"14","author":[{"given":"Riva","family":"Raiker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Hasanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Burkeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millicent","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeesh","family":"Veedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Kolesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lowell","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cavnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"1230_CR1","doi-asserted-by":"crossref","unstructured":"Oronsky B, Ma PC, Morgensztern D,Carter CA. Nothing But NET: A review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19:991\u20131002.","DOI":"10.1016\/j.neo.2017.09.002"},{"key":"1230_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol"},{"issue":"4","key":"1230_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/cncr.31124","volume":"124","author":"A Dasari","year":"2018","unstructured":"Dasari A, Mehta K, Byers LA, Sorbye H, Yao JC. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases. Cancer. 2018;124(4):807\u201315.","journal-title":"Cancer"},{"key":"1230_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","volume":"39","author":"DS Klimstra","year":"2010","unstructured":"Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707\u201312.","journal-title":"Pancreas."},{"key":"1230_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.21037\/tlcr.2017.06.12","volume":"6","author":"K Hiroshima","year":"2017","unstructured":"Hiroshima K, Mino-Kenudson M. Update on large cell neuroendocrine carcinoma. Transl Lung Cancer Res. 2017;6:530\u20139.","journal-title":"Transl Lung Cancer Res"},{"key":"1230_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1097\/00000478-200010000-00014","volume":"24","author":"M Papotti","year":"2000","unstructured":"Papotti M, Cassoni P, Sapino A, et al. Large cell neuroendocrine carcinoma of the gallbladder: report of two cases. Am J Surg Pathol. 2000;24:1424\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1230_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fonc.2013.00002","volume":"3","author":"K Hirabayashi","year":"2013","unstructured":"Hirabayashi K, Zamboni G, Nishi T, et al. Histopathology of gastrointestinal neuroendocrine neoplasms. Front Oncol. 2013;3:2.","journal-title":"Front Oncol"},{"key":"1230_CR8","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.3748\/wjg.v19.i28.4616","volume":"19","author":"E Sasatomi","year":"2013","unstructured":"Sasatomi E, Nalesnik MA, Marsh JW. Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature review. World J Gastroenterol. 2013;19:4616\u201323.","journal-title":"World J Gastroenterol"},{"key":"1230_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2152\/jmi.60.149","volume":"60","author":"T Nakagawa","year":"2013","unstructured":"Nakagawa T, Sakashita N, Ohnishi K, Komohara Y, Takeya M. Imprint cytological feature of large cell neuroendocrine carcinoma of the gallbladder: a case report. J Med Investig. 2013;60:149\u201353.","journal-title":"J Med Investig"},{"key":"1230_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/dc.22872","volume":"41","author":"A Samad","year":"2013","unstructured":"Samad A, Kaplan A, Arain M, et al. Endoscopic ultrasound-guided fine-needle aspiration diagnosis of large cell neuroendocrine carcinoma of the gallbladder and common bile duct: report of a case. Diagn Cytopathol. 2013;41:1091\u20135.","journal-title":"Diagn Cytopathol"},{"key":"1230_CR11","doi-asserted-by":"crossref","unstructured":"Buscemi S, Orlando E, Damiano G, et al. \u201cPure\u201d large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature. Int J Surg. 2016;28 Suppl 1:S128\u2013S132.","DOI":"10.1016\/j.ijsu.2015.12.045"},{"key":"1230_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s40792-016-0269-8","volume":"2","author":"M Murakami","year":"2016","unstructured":"Murakami M, Katayama K, Kato S, et al. Large-cell neuroendocrine carcinoma of the common bile duct: a case report and a review of literature. Surg Case Rep. 2016;2:141.","journal-title":"Surg Case Rep"},{"key":"1230_CR13","doi-asserted-by":"publisher","first-page":"18048","DOI":"10.3748\/wjg.v20.i47.18048","volume":"20","author":"SB Park","year":"2014","unstructured":"Park SB, Moon SB, Ryu YJ, et al. Primary large cell neuroendocrine carcinoma in the common bile duct: first Asian case report. World J Gastroenterol. 2014;20:18048\u201352.","journal-title":"World J Gastroenterol"},{"key":"1230_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12029-015-9745-9","volume":"46","author":"M Kamboj","year":"2015","unstructured":"Kamboj M, Gandhi JS, Gupta G, et al. Neuroendocrine carcinoma of gall bladder: a series of 19 cases with review of literature. J Gastrointest Cancer. 2015;46:356\u201364.","journal-title":"J Gastrointest Cancer"},{"key":"1230_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/pgmj.2008.070649","volume":"85","author":"S Iype","year":"2009","unstructured":"Iype S, Mirza TA, Propper DJ, et al. Neuroendocrine tumours of the gallbladder: three cases and a review of the literature. Postgrad Med J. 2009;85:213\u20138.","journal-title":"Postgrad Med J"},{"key":"1230_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00004728-200607000-00009","volume":"30","author":"SR Jun","year":"2006","unstructured":"Jun SR, Lee JM, Han JK, Choi BI. High-grade neuroendocrine carcinomas of the gallbladder and bile duct: report of four cases with pathological correlation. J Comput Assist Tomogr. 2006;30:604\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"1230_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10147-008-0843-6","volume":"14","author":"C Shimono","year":"2009","unstructured":"Shimono C, Suwa K, Sato M, et al. Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment. Int J Clin Oncol. 2009;14:351\u20135.","journal-title":"Int J Clin Oncol"},{"key":"1230_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/jjco\/hyt033","volume":"43","author":"Y Okuyama","year":"2013","unstructured":"Okuyama Y, Fukui A, Enoki Y, et al. A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET\/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition. Jpn J Clin Oncol. 2013;43:571\u20134.","journal-title":"Jpn J Clin Oncol"},{"key":"1230_CR19","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.3748\/wjg.v22.i30.6960","volume":"22","author":"Y Oshiro","year":"2016","unstructured":"Oshiro Y, Gen R, Hashimoto S, et al. Neuroendocrine carcinoma of the extrahepatic bile duct: a case report. World J Gastroenterol. 2016;22:6960\u20134.","journal-title":"World J Gastroenterol"},{"key":"1230_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","volume":"15","author":"AX Zhu","year":"2010","unstructured":"Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010;15:168\u201381.","journal-title":"Oncologist."},{"key":"1230_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11748-014-0379-9","volume":"62","author":"A Iyoda","year":"2014","unstructured":"Iyoda A, Makino T, Koezuka S, Otsuka H, Hata Y. Treatment options for patients with large cell neuroendocrine carcinoma of the lung. Gen Thorac Cardiovasc Surg. 2014;62:351\u20136.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"1230_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.lungcan.2012.04.009","volume":"77","author":"JM Sun","year":"2012","unstructured":"Sun JM, Ahn MJ, Ahn JS, et al. Chemotherapy for pulmonary large cell neuroendocrine carcinoma: similar to that for small cell lung cancer or non-small cell lung cancer? Lung Cancer. 2012;77:365\u201370.","journal-title":"Lung Cancer"},{"key":"1230_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jjco\/hyp173","volume":"40","author":"S Iwasa","year":"2010","unstructured":"Iwasa S, Morizane C, Okusaka T, et al. Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas. Jpn J Clin Oncol. 2010;40:313\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"1230_CR24","doi-asserted-by":"crossref","unstructured":"Miyoshi T, Umemura S, Matsumura Y, et. al. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clin Cancer Res. 2017;23(3):757\u2013765. 9.","DOI":"10.1158\/1078-0432.CCR-16-0355"},{"issue":"14","key":"1230_CR25","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","volume":"22","author":"N Rekhtman","year":"2016","unstructured":"Rekhtman N, Pietanza MC, Hellmann MD, et al. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets. Clin Cancer Res. 2016;22(14):3618\u201329.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1230_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/PAS.0b013e3182417d36","volume":"36","author":"S Yachida","year":"2012","unstructured":"Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, DeMarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CA. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36(2):173\u201384.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"1230_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1097\/MPA.0b013e3181ec1261","volume":"39","author":"LB Anthony","year":"2010","unstructured":"Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB 3rd, Pommier RF. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas. 2010;39(6):767\u201374.","journal-title":"Pancreas"},{"key":"1230_CR28","unstructured":"Patel, et al. A phase II basket trial of nivolumab and ipilimumab in rare tumors (NET cohort). AACR 2019. Abstract #CT039."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1230-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1230-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T01:48:00Z","timestamp":1605836880000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1230-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1230"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1230-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable\/Abstracted Information.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable\/Abstracted Information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}